Precision radiation targets prostate tumors, spares healthy tissue

This study tests a new type of radiation therapy for men with low to intermediate risk prostate cancer. The treatment uses MRI scans to give a higher radiation dose directly to the tumor while lowering the dose to the rest of the prostate, aiming to control the cancer with fewer side effects. About 58 participants will receive this radiation over two weeks and be followed for up to five years. The main goal is to see if this approach is safe and does not cause serious urinary or bowel problems.